Table 2. Antimicrobial resistance patterns of Streptococcus suis and other Streptococcus spp. isolates from meningitis patients in 2 rural districts in northern Togo, 2010–2014 .
| Antimicrobial drug | No. S. suis samples tested/no. (%) susceptible |
No. other Streptococcus spp. samples tested/no. (%) susceptible | |
|---|---|---|---|
| Tested at local laboratory* | Tested at reference laboratory† | ||
| Amoxicillin | 15/15 (100) | 11/10 (91) | 9/5 (56) |
| Cefotaxime | 0 | 11/10 (91) | 0 |
| Ceftriaxone | 15/15 (100) | 0 | 9/8 (89) |
| Chloramphenicol | 15/12 (80) | 11/11 (100) | 9/8 (89) |
| Clindamycin | 0 | 11/10 (91) | 0 |
| Cotrimoxazole | 15/14 (93) | 0 | 9/6 (67) |
| Gentamicin | 15/7 (47) | 0 | 9/4 (44) |
| Levofloxacin | 0 | 11/10 (91) | 0 |
| Oxacillin | 12/3 (25) | 11/11 (100) | 1/0 |
| Penicillin | 15/15 (100) | 11/10 (91) | 9/5 (56) |
| Rifampin | 15/15 (100) | 0 | 9/6 (67) |
| Tetracycline | 0 | 11/0 | 0 |
*The regional bacteriology laboratory in Dapaong, Togo. †National Reference Center for Streptococci in Aachen, Germany.